Breaking News, Collaborations & Alliances

HJB and Ansun Biopharma Enter Biologics Collaboration

CMC development and manufacturing partnership expecting to submit an IND application in 2021.

By: Contract Pharma

Contract Pharma Staff

HJB, a biologics contract development and manufacturing organization (CDMO), has entered into a partnership for CMC development and manufacturing with Ansun Biopharma on its therapeutic biologics pipeline. The first program is expecting to submit an Investigational New Drug (IND) application in 2021.   Ansun will have the ability to leverage HJB’s expertise and capacities from cell line development, process and assay development to GMP manufacturing, IND-enabling full-service package and c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters